Earlier studies have demonstrated that CSCs in breast cancer (BCSC) are marked by various proteins including DCLK1, aldehyde dehydrogenase (Aldh1), CD44high/CD24low, and CD133 [6,7,8]. This evidence concerns the gene DCLK1 and breast cancer.